Endometrial Cancer Therapy Combo Fails 1L Treatment Trial Endometrial Cancer Therapy Combo Fails 1L Treatment Trial
Merck said on Friday a combination therapy being developed with partner Eisai failed a late-stage trial testing it as a first-line treatment for a type of cancer in the uterus lining.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Cancer Therapy | Endometrial Cancer | Health | Hematology | Merck